Literature DB >> 12713869

p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma.

Carolina Armengol1, Loreto Boix, Oriol Bachs, Manel Solé, Josep Fuster, Margarita Sala, Josep M Llovet, Juan Rodés, Jordi Bruix.   

Abstract

BACKGROUND/AIMS: Alterations in p27(Kip1) (p27) and cyclin E (cycE) expression are found in tumors and are related to poor prognosis. This study assesses the role of these cell cycle regulators in the development of recurrence after surgical resection in 46 cirrhotic patients (age: 61.3+/-7 years, 30 males, 44 Child-Pugh's A, 30 HCV-positive) with small hepatocellular carcinoma (HCC, size: 3.1+/-1.5cm, 40 solitary at pathological examination).
METHODS: p27 and cycE expression in tumoral and non-tumoral liver were analyzed by Western blot (WB). p27 was also assessed by immunohistochemistry (IHC).
RESULTS: Tumor p27 underexpression (50% decreased vs. non-tumoral liver) occurred in 12 cases. Throughout follow-up, 26 patients developed recurrence, which was significantly higher in patients with p27 underexpression than in those without (3-year recurrence: 80 vs. 44%, respectively, P=0.026). IHC showed concordant inverse findings: 13 tumors showed high p27 staining that was related to lower recurrence rate (P=0.019). Multivariate analysis identified p27 measured by WB as an improved predictor of recurrence (OR: 3.09, 95% CI: 1.26-7.08, P=0.016). By contrast, cycE, increased in 66% of the tumors, had no impact on recurrence but was associated to poor differentiation (P=0.015) and microvascular invasion (P=0.016).
CONCLUSIONS: p27 underexpression is frequent in relatively early stages of HCC and constitutes an independent predictor of recurrence after surgical resection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12713869     DOI: 10.1016/s0168-8278(03)00025-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

Review 1.  Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Mei Wang
Journal:  World J Hepatol       Date:  2015-01-27

2.  Genetic polymorphisms in apoptosis-related genes and the prognosis of hepatocellular carcinoma.

Authors:  Guo-Peng Yu; Qian-Yi Xiao; Zhu-Qing Shi; Li-Sha Tang; Xiao-Pin Ma; Lu-Yao Zhang; Hai-Tao Chen; Wen-Jia Wang; Peng-Yin Zhang; Dong-Lin Ding; Hui-Xing Huang; Hexige Saiyin; Tao-Yang Chen; Pei-Xin Lu; Neng-Jin Wang; Hong-Jie Yu; Jie-Lin Sun; S Lilly Zheng; Jian-Feng Xu; Long Yu; De-Ke Jiang
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

3.  Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma.

Authors:  Azza E El Bassiouny; Mona M Nosseir; Mona K Zoheiry; Noha A Ameen; Ahmed M Abdel-Hadi; Ibrahim M Ibrahim; Suher Zada; Abdel-Hakeem Saad El-Deen; Nora E El-Bassiouni
Journal:  World J Hepatol       Date:  2010-01-27

4.  Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma.

Authors:  Jun Cui; Bao-Wei Dong; Ping Liang; Xiao-Ling Yu; De-Jiang Yu
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

Review 5.  Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.

Authors:  Yasunobu Matsuda
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

6.  Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma.

Authors:  Ke-Jun Nan; Zhao Jing; Ling Gong
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

Review 7.  Clinical significance of cell cycle inhibitors in hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Masayuki Kubota; Masaaki Takamura; Satoshi Yamagiwa; Yutaka Aoyagi; Mami Osawa; Shun Fujimaki; Ayumi Sanpei; Takuya Genda; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2013-05-03       Impact factor: 2.309

8.  Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics.

Authors:  Nil Culhaci; Ozgul Sagol; Sedat Karademir; Huseyin Astarcioglu; Ibrahim Astarcioglu; Mujde Soyturk; Ilhan Oztop; Funda Obuz
Journal:  BMC Cancer       Date:  2005-08-08       Impact factor: 4.430

9.  TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.

Authors:  Dong-Sheng Zhou; Hong-Bo Wang; Zhong-Guo Zhou; Yao-Jun Zhang; Qian Zhong; Li Xu; Yue-Hua Huang; Sai-Ching Yeung; Min-Shan Chen; Mu-Sheng Zeng
Journal:  Oncotarget       Date:  2015-09-15

Review 10.  Role of p27Kip1 as a transcriptional regulator.

Authors:  Oriol Bachs; Edurne Gallastegui; Serena Orlando; Anna Bigas; José Manuel Morante-Redolat; Joan Serratosa; Isabel Fariñas; Rosa Aligué; Maria Jesús Pujol
Journal:  Oncotarget       Date:  2018-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.